Alendronate and Levothyroxine: Keep Both Fasting Instructions

At a glance

  • Standard alendronate tablet / first medication after rising, plain water only
  • Minimum wait before another medication / at least 30 minutes
  • Levothyroxine tablet / empty stomach, 30 to 60 minutes before breakfast
  • Proven absorption loss from standard tablets / not established by the cited evidence
  • Concurrent-dose study / 30 healthy adults; new effervescent alendronate formulation
  • Applicability of that study to standard tablets / not established
  • Individual schedule / confirm with prescriber or pharmacist

Read each tablet label before combining the clocks

The most reliable answer begins with each product's label. Standard alendronate tablets must be taken at least 30 minutes before the day's first food, beverage, or medication, with plain water only. The patient must remain upright for at least 30 minutes and until after the first food of the day [1].

Levothyroxine tablets are labeled for once-daily use on an empty stomach, one-half to one hour before breakfast. The label also says to separate drugs known to interfere with levothyroxine absorption by at least four hours, but the cited label does not name alendronate in that group [2].

Those instructions create a scheduling conflict. They do not, by themselves, prove that alendronate chelates levothyroxine or reduces its exposure by a particular percentage.

The current alendronate label makes its priority explicit: “Take alendronate sodium tablets at least one-half hour before the first food, beverage, or medication of the day with plain water only.” [1] The levothyroxine label adds its own fasting interval.

Preserve the wait before the next medicine and before food

StepStandard alendronate tablet instructionLevothyroxine instructionEvidence boundary
On risingtake alendronate with 6 to 8 ounces of plain water [1]not yet takenalendronate label says it precedes every other medication
Next 30 minutesno food, beverage, or other medication; remain upright [1]wait30 minutes is the alendronate minimum, not a universal interaction interval
After that minimumanother medication may follow under the alendronate label [1]take levothyroxine if this is the agreed schedule [2]confirm the sequence for the actual products and patient
Before breakfastcontinue to remain upright until after the first food [1]preserve the labeled 30-to-60-minute empty-stomach interval [2]do not collapse both labels into one 30-minute wait
Calcium, iron, antacids, or other bindersfollow alendronate separation instructions [1]some products require at least four hours from levothyroxine [2]check every product rather than applying one blanket rule

The matrix is a reconciliation of two labels. It is not a clinical trial of this exact morning sequence.

What the Direct Interaction Study Actually Tested

The relevant 2017 randomized, open-label, three-way crossover study enrolled 30 healthy adults. It compared levothyroxine alone, a new effervescent formulation of alendronate alone, and the two taken concurrently after an overnight fast. The investigators reported no clinically important pharmacokinetic interference for that effervescent formulation [3].

Important limits:

  • the study used 600 micrograms of levothyroxine as a single research dose, not each participant's routine replacement regimen;
  • participants were healthy adults, not patients being titrated for hypothyroidism;
  • it measured short-term pharmacokinetics, not long-term TSH control or fractures;
  • it tested a specific new effervescent alendronate formulation.

The reported geometric mean ratios for concurrent versus separate administration were 0.927 for alendronate total exposure and 0.912 for its peak concentration. Their 90% intervals were 0.795–1.081 and 0.773–1.077, extending below the study’s default 0.80–1.25 reference band. Levothyroxine’s ratios were 1.049 and 1.075, with intervals of 0.983–1.119 and 1.006–1.148, inside that band. The authors concluded there was no clinically important interference; the interval results still deserve formulation-specific interpretation.[3]

The result corrects a common overstatement: concurrent dosing is not proven to reduce levothyroxine absorption by 29%, 50%, or any other fixed amount. It also does not override standard tablet labeling.

Check the products against your actual morning

Bring this record to the prescriber or pharmacist instead of relying on memory:

FieldRecord
Alendronatestrength, tablet or effervescent product, daily or weekly schedule
Levothyroxinebrand/manufacturer, strength, tablet/capsule/liquid, current timing
Breakfastusual time after waking
Other morning productscoffee, calcium, iron, antacids, fiber, supplements, other prescriptions
Relevant constraintsswallowing difficulty, shift work, inability to remain upright, fasting requirements
Agreed sequenceexact time and interval for each item
Follow-upwho will review symptoms or thyroid laboratory results, and when

Formulation matters. Do not use the effervescent study to change how a standard alendronate tablet is taken, and do not assume every levothyroxine dosage form has identical instructions.

If the Morning Sequence Is Impractical

Do not independently take standard alendronate with levothyroxine or move levothyroxine to a different time. Ask the prescriber or pharmacist to reconcile the actual product labels and daily routine. Possibilities may include keeping the extended morning sequence, choosing a different levothyroxine time, or reconsidering dosage form, but each changes adherence and may require follow-up.

The goal is consistency with an agreed schedule. A theoretically perfect schedule that the patient cannot follow is not a durable solution.

When to Contact the Care Team

Ask for individualized help if:

  • the alendronate product is not a standard tablet;
  • the levothyroxine product or manufacturer changes;
  • calcium, iron, antacids, or tube feeding complicate the schedule;
  • the patient cannot remain upright as instructed;
  • doses are being missed to make the timing work; or
  • symptoms or thyroid laboratory results change after the regimen changes.

Do not double a dose or adjust levothyroxine based on this page.

Frequently asked questions

Can alendronate and levothyroxine be used by the same person?
They may be prescribed together, but their fasting instructions must be reconciled for the actual formulations. Ask the prescriber or pharmacist for the schedule.
Which medicine comes first in the morning?
The standard alendronate tablet label says it must come before the day's first food, beverage, or other medication.
Is 30 minutes enough between alendronate and breakfast when levothyroxine follows?
Not under the two cited labels combined. After alendronate's minimum wait, levothyroxine still has its own labeled 30-to-60-minute pre-breakfast interval.
Does alendronate reduce levothyroxine absorption by 50%?
No verified study cited here establishes a fixed 50% reduction. The direct study of a new effervescent alendronate formulation found no clinically important pharmacokinetic interference.
Can the effervescent alendronate study be applied to Fosamax tablets?
No. It tested a specific new effervescent formulation, so its concurrent-dosing result should not be generalized to standard tablets.
Should levothyroxine be moved to bedtime?
Only after the prescriber or pharmacist confirms a suitable, consistent schedule for the specific levothyroxine product and the patient's routine.

References

  1. DailyMed / U.S. National Library of Medicine. Alendronate sodium tablets, current U.S. prescribing information. Label page updated February 16, 2026; revised June 2025. See section 2.6, Important Administration Instructions. Current alendronate tablet label
  2. DailyMed / U.S. National Library of Medicine. Levothyroxine sodium tablets, current U.S. prescribing information. See section 2.1, General Administration Information. Current levothyroxine tablet label
  3. Bone HG, Walter MA, Hurley ME, Epstein S. Pharmacokinetics of coadministration of levothyroxine sodium and alendronate sodium new effervescent formulation. Osteoporos Int. 2017 May;28(5):1745-1752. doi:10.1007/s00198-017-3941-3. PMID:28204953. PMCID:PMC5393287. PubMed record PMC full text
Four reported geometric mean pharmacokinetic ratios and 90 percent intervals in 30 healthy adults given a specific effervescent alendronate formulation and levothyroxine research doses.
Reported formulation-specific study estimates; this study does not establish a standard-tablet dosing schedule. Image: HealthRX.com original evidence diagramView full-size diagram